Table 1 The clinical characteristics of ten cases of DM/PM treated with AHSCT in articles
First Author/Year | diseases | n | Gender | age | Treatment before HSCTa | Mobilization | Conditioning | Improve | Follow-up (months) | complication |
|---|---|---|---|---|---|---|---|---|---|---|
Baron, 2000 [17] | PM | 1 | Female | 28 | Pred, AZA, MTX, CTX | CTX + G-CSF | ATG, CTX | yes | 12 | severe ARDS; fevers and chills by ATG |
Chakraverty,2001 [4] | DM | 1 | Male | 46 | DEX, vincristine, adriamycin | CTX + G-CSF | melphalan | yes | 18 | severe mucositis |
Bingham, 2001 [21] | PM | 1 | Female | 38 | Pred, CTX, CsA, AZA, IVIG, plasmapheresis | CTX + G-CSF | – | yes | 24 | no |
Oryoji, 2005 [5] | DM | 1 | Female | 54 | Pred, CsA, CTX | CTX + G-CSF | CTX | Yes | 12 | Cytomegalovirus antigenemia |
Henes, 2009 [18] | PM | 1 | Male | 32 | Pred, AZA, MTX, CsA, MMF, IVIG, CTX, alemtuzumab, RTX, IFX | CTX + G-CSF | CTX, ATG | Yes | 36 | No |
Holzer, 2010 [19] | JDM | 2 | Female | 12 | Pred, MTX, CsA, IVIG, RTX | CTX + G-CSF | ATG, CTX,fludarabine | yes | 26 | No |
8 | Pred, MTX, CTX, RTX, tacrolimus | CTX + G-CSF | ATG, CTX,fludarabine | Yes | 13 | No | ||||
Storek, 2013 [6] | DM | 1 | Male | 22 | Pred, IVIG, AZA, MMF, CTX, CsA, IFX, RTX | CTX + G-CSF | CTX, ATG | no | 3 | No |
Enders,2015 [20] | JDM | 3 | – | – | – | – | – | Yes | 36–60 | – |